HomeDeal TypeBuy OutThe Netherlands: Smile Invest acquires majority stake in BAP Medical

The Netherlands: Smile Invest acquires majority stake in BAP Medical

-

Smile Invest has acquired a majority stake in BAP Medical, alongside management and founder Rob Hollweg. With this investment, Smile Invest welcomes a new company to its portfolio, a specialised market leader in medical devices in the Benelux with clear international ambitions.

Founded in 2006, BAP Medical has developed into an international organisation that supports healthcare professionals and patients with medical solutions in the field of scar care, wound care, allergies and ENT care, among others.

From its own production facility in Belgium, operating under the name ScarPro, BAP Medical reaches practitioners and patients in more than 70 countries through its own sales organisations in the Netherlands, Belgium, the UK, and a worldwide distribution network.

“Smile Invest fits in perfectly with the culture and ambitions of BAP Medical. Together, we are taking the next step in our growth, while continuing to invest in innovative medical solutions that add value for healthcare professionals and patients,” said Rob Hollweg, CEO BAP Medical

Smile Invest also sees a strong match between the two organisations.

“What immediately appealed to us about BAP Medical is the combination of scientific depth and an entrepreneurial culture that is strongly focused on both patient and customer. Rob and his team have built up a portfolio of strong brands over twenty years that doctors and specialists recommend on a daily basis. We see plenty of room to further accelerate international growth together and look forward to the future collaboration with BAP Medical,” said Ivo Vincente, Davy Louwers and Nicolas Costers, Smile Invest

Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

Advertisement

Related Resources

Related Events